We Are Uniting for Lung Cancer Awareness

Everyone is invited to register for the virtual Breathe Deep Anywhere event, but those who can join in person in DC, New York, Boston, or Chicago, on Saturday, November 4, get to be part of the community walk, enjoy kid and family-friendly activities, and explore the new lung cancer Resource Fair. 

Your involvement sends a resounding message: The lung cancer community is united. And to show just how united we are, everyone who signs up today gets a free Breathe Deep TOGETHER shirt! 

International Lung Cancer Survivorship Conference 

Register today and join us on September 22-23 for the International Lung Cancer Survivorship Conference. This free, virtual event brings the world’s lung cancer experts directly to you with the latest information on your type of lung cancer, complementary and alternative medicine approaches, brain metastasis, and more. 

New to the agenda this year are regional “Ask the Expert” sessions focused on the geographic areas of Asia and Australia, Europe and Middle East/North Africa, and Latin America, in addition to North America. The lung cancer experts leading these sessions will take questions and share regional-specific information on the area they serve. 

You can see the current conference agenda here.  

Continued Collection of Patient-Reported Outcomes After the End of a Clinical Trial

LUNGevity’s Bellinda King-Kallimanis, PhD, Director of Patient-Focused Research, and LUNGevity board member Nichelle Stigger just published a paper on the importance of continuing to ask patients to fill in surveys about how they feel and function after clinical trial treatment ends. 

In the article, the results of a roundtable conversation that included patients, academics, regulatory agencies, clinicians, and other stakeholders are shared. Together, this group created recommendations to help collect follow-up data from the patient perspective after they have left a clinical trial, or the trial ends.  

The roundtable participants unanimously agreed there is value in knowing how patients feel and function after treatment ends on a clinical trial, and this information should come from the patients themselves. 

Did You Miss It? 

In partnership with UChicago Medicine, the July Learn with LUNGevity webinar brought together internationally recognized experts to talk about the latest in lung cancer treatment and ways to navigate a lung cancer diagnosis. Watch the recording here.

The recent Facebook Live on Moving beyond tyrosine kinase inhibitors: What's new in RET-positive lung cancer is still available to watch here. 

1st NYC Young Professionals Party 

We are thrilled to incorporate the first-ever Young Professionals Party into our long-standing NYC Celebration of Hope & Progress Gala and introduce a new group of supporters to LUNGevity’s transformative work. The event is designed for young professionals to enjoy a fun-filled evening of networking, entertainment, and supporting an important cause. 

Supporting the Future Oncology Workforce 

For the second year, LUNGevity is supporting three first-year medical students at Temple University, exposing them to research in thoracic oncology through a mentorship by Dr. Cherie Erkmen. A similar program was launched at Morehouse University this summer as part of our commitment to diversify the thoracic oncology workforce. 

Learn more about our commitment to supporting the thoracic oncology workforce through research grants.